Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF in embryo culture for repeated implantation failure
NCT02250768Phase 4Completed
- Sponsor
- Vietnam National University
- Start
- Jul 2013
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sargramostim in Repeated Implantation Failure (RIF), sponsored by Vietnam National University. Primary endpoint: Ongoing pregnancy rate at 12 weeks. Started Jul 2013; status: completed.
02
Drugs
sargramostim
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT02250768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250768.